TCRs Genetically Linked to CD28 and CD3ε Do Not Mispair with Endogenous TCR Chains and Mediate Enhanced T Cell Persistence and Anti-Melanoma Activity-Reference-Cited by-同舟云学术

TCRs Genetically Linked to CD28 and CD3ε Do Not Mispair with Endogenous TCR Chains and Mediate Enhanced T Cell Persistence and Anti-Melanoma Activity

Published:2014-10-15 Issue:10 Volume:193 Page:5315-5326
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Govers Coen,Sebestyén Zsolt,Roszik János,van Brakel Mandy,Berrevoets Cor,Szöőr Árpád,Panoutsopoulou Konstantina,Broertjes Marieke,Van Tan,Vereb György,Szöllősi János,Debets Reno

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference63 articles.

1. TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu

2. Rosenberg, S. A. 2012. Raising the bar: the curative potential of human cancer immunotherapy. Sci. Transl. Med. 4: 127ps8.

3. Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

4. Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1

5. Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toward a comprehensive solution for treating solid tumors using T-cell receptor therapy: A review;European Journal of Cancer;2024-09

2. Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies;Nature Cancer;2024-03-19

3. Basigin binds bacteria and activates Dorsal signaling to promote antibacterial defense in Penaeus vannamei;Fish & Shellfish Immunology;2023-11

4. Modifications outside CDR1, 2 and 3 of the TCR variable β domain increase TCR expression and antigen-specific function;Frontiers in Immunology;2023-04-12

5. Engineered Treg cells: The heir to the throne of immunotherapy;Journal of Autoimmunity;2023-01